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Transcatheter Closure of Residual Atrial Septa1 Defect 
Following Implantation of Buttoned Device 
Rolando Zamora, MD, Daniela Lax, MD, Richard L. Donnerstein, MD, and Thomas R. Lloyd, MD 
We report a case in which residual shunting after a buttoned device occlusion of atrial 
septal defect (ASD) was ellmlnated by transcatheter retrieval of a portion of the device, 
followed by implantation of a second device. This method may be helpful for those 
patients with residual ASDs who decline surgical device retrleval and defect closure. 
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INTRODUCTION 
Residual left-to-right shunting is common after trans- 
catheter occlusion procedures for secundum ASD [ 1-31 
but has usually been of minor degree with a clear ten- 
dency to spontaneous resolution. Significant residual 
shunts following device closure of patent ductus arteri- 
osus have been successfully closed by application of ad- 
ditional devices [4,5], but this strategy has not been ap- 
plied to ASD occlusion. We report a case in which 
significant residual shunting after buttoned device occlu- 
sion of ASD was successfully eliminated by transcatheter 
retrieval of a portion of the implanted device, followed 
by implantation of a second buttoned device. 
CASEREPORT 
The patient was a white female who first underwent 
transcatheter closure of ASD at 23 months of age. At that 
time she weighed 10.3 kg and her ratio of pulmonary to 
systemic blood flow was 2.5:1 by oximetry. The balloon 
occlusion diameter [6] of her defect was 18 mm. A but- 
toned device (Custom Medical Devices, Amarillo, TX) 
of 35 mm diagonal dimension was implanted using trans- 
thoracic echocardiographic guidance. Oximetric mea- 
surements after implantation indicated a pulmonary to 
systemic blood flow ratio of 1.5: 1 .  Pulmonary arteriog- 
raphy confirmed a moderate residual shunt, as did 
echocardiography. Since it had been our experience that 
small residual shunts had a tendency to spontaneous res- 
olution [ 2 ] ,  we hoped that with time her shunt would 
decrease. At 1 month follow-up, echocardiography 
showed a smaller residual shunt, with normal interven- 
tricular septal motion and right ventricular size. An arm 
of the occluder was noted to extend through the defect 
into the right atrial cavity, with the opposite arm project- 
ing into the left atrial cavity. At 6-month follow-up, 
device position was unchanged by radiography and 
echocardiography , but the volume of residual shunting 
had greatly increased, as evidenced by echocardio- 
graphic right ventricular enlargement and flat interven- 
tricular septal motion, as well as by return of the systolic 
murmur and widely split second heart sound. At this 
point, surgical device retrieval and repair of ASD [7] was 
offered to the family, but they declined. No further clin- 
ical, radiographic, or echocardiographic changes were 
noted over a total of 22 months of follow-up. At the age 
of 45 months (weight 14 kg), a transcatheter attempt at 
correction of device position was offered, with the pos- 
sibility of device retrieval and/or placement of a new 
device if repositioning failed. This procedure was under- 
taken after obtaining informed consent from the patient’s 
parents under a protocol approved by the Human Sub- 
jects committee of the University of Arizona. 
The procedure was performed under general anesthe- 
sia using transesophageal echocardiographic guidance. 
The ratio of pulmonary to systemic blood flow by oxi- 
metry was 2.8: l .  A 35 mm Amplatz goose-neck snare 
(Microvena Corp., White Bear Lake, MN) was advanced 
to the right atrium to snare the distal end of the occluder 
arm protruding into the right atrium. This arm was then 
manipulated across the ASD. Upon release, the device 
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Fig. 1. The arrow points to the snare grasping the protruding 
occluder arm before traction is applied. 
immediately returned to its original position. This ma- 
neuver was repeated several times with the same result. 
An attempt was then made to retrieve the device. The 
snare was used to grasp the protruding occluder arm as 
near as possible to the center of the occluder (Fig. 1 ) .  
When traction was placed on the device, the device 
would not separate from the atrial septum, even when the 
device and atrial septum were pulled near the orifice of 
the inferior vena cava. With further traction, the arm that 
had been grasped by the snare separated from the device, 
including the wire whose ends formed the skeleton of the 
arms protruding into the right and left atrial cavities. 
These portions of the device remained attached to the 
snare and were easily removed through the femoral 
venous sheath (Fig. 2). 
Transesophageal echocardiography showed that the 
polyurethane foam portion of the arm that had previously 
projected into the left atrial cavity had spontaneously 
retracted to the remainder of the occluder, presenting no 
barrier to proper placement of a second buttoned device. 
The diameter of the residual defect was 9 mm by 
echocardiography; balloon sizing was not attempted be- 
cause of concerns about dislodging foam from the skel- 
eton of the original device. A 30 mm buttoned device 
was advanced to the left atrium through an 8 French 
Mullins sheath, and correct deployment against the atrial 
septum was confirmed by echocardiography (Fig. 3). 
However, when the counteroccluder was advanced, the 
distal arm was inadvertently directed across the defect, 
resulting in an unstable device position after buttoning 
(Fig. 3). The misdirected counteroccluder arm did not 
project into the atrial cavity and thus did not interfere 
with apposition of the near device to the atrial septum, as 
had the previously retrieved occluder arms. Therefore, a 
second counteroccluder was then advanced to the proper 
location in the right atrium and buttoned in series with 
Fig. 2. The retrieved occluder arm is shown. The large black 
arrow points to the core of the wire that formed the skeleton of 
the arms formerly protruding into the left and right atrial cavi- 
ties. Note the outer spring portion of the wire, which has unrav- 
eled (small black arrow). The white arrow shows the polyure 
thane foam from the tip of the arm formerly protruding into the 
right atrial cavity. Note the thorough endothelial coverage of 
this arm despite its lack of contact with the endocardium. The 
arrowhead points to the suture that secured the wire skeleton to 
the Polyurethane foam. 
the first counteroccluder, securing device position. After 
release of this device, six segments of wire skeleton can 
be seen radiographically (Fig. 4): three on the left atrial 
side of the septum (one remaining in the original oc- 
cluder and two in the new occluder), two on the right 
atrial side (the original counteroccluder and the second 
new counteroccluder), and one obliquely crossing the 
ASD (the first new counteroccluder). No left-to-right 
shunt could be detected by oximetry, although angiog- 
raphy and color flow Doppler echocardiography detected 
trivial residual shunting. Transthoracic echocardiography 
confirmed complete resolution of the residual shunting 1 
day following the procedure. At 2 months follow-up, 
radiographic and echocardiographic device position re- 
mains unchanged, with no detectable residual shunt (Fig. 
5). There has been no clinical evidence of systemic or 
pulmonary thromboembolism. 
DISCUSSION 
Clinically significant residual shunting is not a com- 
mon problem after transcatheter occlusion of ASDs with 
the buttoned device. Of 166 cases of successful device 
implantation reported, only six required operation for 
residual shunt, recurrent neurologic symptoms, atrial 
perforation, or wire distortion [3]. The present case was 
the sole patient with persistent residual shunting of 2 
moderate severity in either U.S. [2] or international [3] 
trials of the buttoned device. The residual shunt in this 
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Fig. 3. Transesophageal echocardiographic images of the atrial septum. A: Correct deploy- 
ment against the atrial septum of a 30 mm buttoned device occluder (OC) is confirmed. The 
“button” (9) is noted. 9: The small arrow points to the distal arm of the counteroccluder (COC) 
that was inadvertently directed across the ASD. RA = right atrium; LA = left atrium. 
case was probably due to two factors: inadequate device 
size for defect size, and incorrect device position with 
one occluder arm passing through the septa1 defect. A 40 
mm device is recommended for defects of 16-20 mm 
diameter, but at the original procedure it was thought that 
35 mm was the largest size that could be accepted into 
the left atrium without impingement on the mitral valve 
or pulmonary veins. Placement of the device with an 
occluder arm in the right atrium is not uncommon, oc- 
curring in about half of the cases implanted under trans- 
thoracic echocardiographic guidance [ 81. Proper device 
position is more readily achieved with transesophageal 
echocardiographic guidance [ 81. Misplacement of the 
counteroccluder, as observed with the first attempt to 
button the 30 mm device in this patient, occurs when the 
end of the delivery sheath is far enough into the right 
atrium that the distal end of the counteroccluder is di- 
rected across the ASD before the proximal end is ad- 
vanced out of the sheath. The weak radio-opacity of the 
delivery sheath and the multiple other radio-opaque 
structures (transesophageal probe, occluder skeleton, de- 
livery wire, monitoring catheters) in the area where the 
counteroccluder is delivered may contribute to occur- 
rence of this problem. Use of transeptal sheaths with 
distal radio-opaque markers (developed for radio fre- 
quency ablation procedures) and left anterior oblique 
views, which separate the counteroccluder delivery site 
from potentially distracting images may reduce the like- 
lihood of counteroccluder misplacement. Fortunately, 
the fourth-generation buttoned device includes two but- 
Fig. 4. Six segments of wire skeleton can be seen radiograph- 
ically after release of the device: three on the left atrial side of 
the septum (one remaining in the original occluder [OCl] and 
two in the new occluder [OC2]), two on the right atrial side (the 
original counteroccluder [COCl] and the second new coun- 
teroccluder [Coca]), and one obliquely crossing the ASD (the 
first new counteroccluder [COCS]). 
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Fig. 5. Subcostal noninverted echocardiographic image of the atrial septum at two months 
follow-up. A: The arrow points to the malpositioned arm of second new counteroccluder (COC2 
from figure 4). B: With color flow Doppler interrogation there is no evidence of a residual shunt. 
tons in series, as in the buttoned device for patent ductus 
arteriosus [9], while retaining the concentric radio- 
opaque button design of the third generation buttoned 
device [3]. The additional button allowed placement of a 
second counteroccluder with confidence. We thought 
that this approach was safer than trying to retrieve the 
misplaced counteroccluder, since the risks of retrieving 
the newly placed occluder along with it was high. 
Residual ASD after buttoned device implantation was 
successfully treated in this patient by placement of a 
second buttoned device after partial retrieval of the orig- 
inal device. We would have preferred to retrieve the 
entire original device, because placement of a second 
buttoned device, especially with two counteroccluders, 
substantially increased the amount of foreign material in 
this child’s heart, which may increase the risk for throm- 
botic or thrornboembolic complications. We plan to treat 
this patient with aspirin (81 mg/day) for at least 6 
months, as opposed to the 6-12 weeks usually recom- 
mended. At least partial device retrieval was necessary in 
this patient because the arm projecting into the left atrial 
cavity would have interfered with proper positioning of 
the second device. We suspect that perforation of the 
right atrium or inferior vena cava could occur during 
been a potential complication. We believe the device 
came apart as it did because of the through tissue in- 
growth and endothelial coverage. 
Our experience with this case has increased our con- 
fidence that the buttoned device will heal in a secure and 
nonthrombogenic manner into the atrial septum. The dif- 
ficulties we encountered with repositioning and retriev- 
ing the device indicate that the device is firmly attached 
to the atrial septum at its points of apposition, and in- 
spection of the foam portion of the retrieved occluder 
arm also demonstrates thorough tissue ingrowth and en- 
dothelial coverage of the device (Fig. 2). Although 
clearly it is best to prevent significant residual shunting 
by accurate application of an appropriate size occlusion 
device, the method described for occlusion of residual 
shunts with a second buttoned device may be helpful for 
those patients with residual ASDs who do not elect to 
undergo surgical device retrieval and defect closure. 
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